Rem3dy Health Limited announced that it has £14 million in a round of funding co-led by new investors UPSA SAS, Apollo Hospitals Enterprise Limited, Desymo Gestion Y Desarrollo De Inmuebles, Suntory Global Spirits Inc. on June 9, 2026. The transaction include participation from new investors Future Planet Capital. The company has issued convertible preferred stock in the transaction.

The transaction was raised at a post-money valuation of £84 million.